FiercePharma18d
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...
Yahoo Finance18d
FDA CDER director Patrizia Cavazzoni announces resignation
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...
STAT18d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration ... will take Cavazzoni’s place pending ethics clearance, FDA Commissioner Robert Califf said in an email reviewed by STAT.
Benzinga.com18d
Patrizia Cavazzoni, head of FDA's drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18. The director shared the news with staff on Friday ...
Investing15d
RBC Capital sees FDA shakeup as risk to biotech stocks
On Monday, the biotechnology sector faced new uncertainties as RBC Capital Markets analysts highlighted potential risks following the resignation of Dr. Patrizia Cavazzoni from the U.S. Food and ...
Becker's Hospital Review18d
FDA drug evaluation leader to exit
The director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, MD, will step down from the role Jan. 18, according to an Endpoints News report. Dr. Cavazzoni joined the FDA ...
Investing15d
RBC Capital sees FDA shakeup as risk to biotech stocks
On Monday, the biotechnology sector faced new uncertainties as RBC Capital Markets analysts highlighted potential risks following the resignation of Dr. Patrizia Cavazzoni from the U.S. Food and Drug ...